Best of Bloomberg Technology For Week Ending February 24 2017

February 24, 2017: The best interviews and technology news highlights from the week are brought together in “Best of Bloomberg Technology,” a weekly long-form program, hosted by Bloomberg Technology’s Cory Johnson.

The show talks about Snapchat. My opinion on the Snapchat IPO is that there is no way Snapchat should be valued at $20 billion. Snap’s monetization model is nothing new. Basically Snap tries to get more eyeballs on their software that they can serve ads to. The problem I have with Snap is that it appeals to a younger, more self-centered and immature audience. These are precisely the types of consumers that don’t buy things. With the majority of Snap chat users being below the age of 18, advertisers on Snap chat will quickly realize that while their ads may get clicks, the type of people who click their Snap ads are not actually buying anything.

Full Show: Best of Bloomberg Technology (02/24)

Analyst Actions and Breaking News

Overnight Analyst Actions:

Raised: None

Initiates: None

Cuts: None

Overnight Headlines By Ticker:

PLX Protalix Biotherapeutics Inc

12/27 07:30 Receives confirmation of order for over $24M of alfataliglicerase to treat gaucher patients in Brazil

PTLA Portola Pharmaceuticals

12/27 07:49 Price Target raised to $29 from $20 at Credit Suisse, reiterates Neutral rating

SGEN Seattle Genetics

12/27 08:00 Announces clinical hold on several Phase 1 trials of Vadastuximab Talirine after deaths [SELL NO LONGER COVERING]

12/27 07:55 Trading halted; news pending; to resume trading at 08:30ET

Pharmaceutical Drug Pricing

Pharmaceutical drug pricing is all over the mainstream financial media right now. Let’s examine the macroeconomics of what is happening.

The demand for pharmaceutical drugs is inelastic. People that need a pharmaceutical drug prescribed by their doctor will demand that drug regardless of price. As the price of the drug goes up, demand mostly stays the same.
Continue reading “Pharmaceutical Drug Pricing”

TEGNA Nice Way To Profit From Increased Political Ads

TEGNA Inc operates 46 television stations that produce local programmings, such as news, sports, and entertainment. The company also operates, CareerBuilder, among other digital properties.

TEGNA is the largest independent owner of NBC and CBS affiliates. Profit more than doubled in the most recent quarter because of political advertising. The Wall Street Journal writes

Chief Executive Gracia Martore said the company expects political revenue to ramp up steadily in the third and fourth quarters as a longer-than-usual primary process led to delayed ad purchases from front-running candidates. She also pointed to “robust advertising from the Olympics this summer driven by our strong NBC footprint.”

TEGNA Stock Chart

The chart shows a beautiful candle over candle reversal that has breached above the speed lines.

I like the stop loss just below $20.82 in case the trade goes south.

Disclosure: I do not hold any stock in TEGNA at the time of publishing this article.